Viral Pleuritis - Biotech, Pharma and Life Science Channel

10:54 EDT 3rd May 2015 | BioPortfolio

Viral pleuritis is a viral infection of the pleurae.

Viral pleuritis is most commonly caused by infection with coxsackie B virus. Occasionally, echovirus causes a rare condition known as epidemic or Bornholm's pleurodynia, manifesting as pleuritis, fever, and chest muscle spasms. The condition occurs in the late summer and affects adolescents and young adults. The primary symptom of viral pleuritis is pleuritic pain; pleural friction rub may be a sign.  Diagnosis is suspected in patients with pleuritic chest pain with or without systemic symptoms of viral infection. Chest x-ray is usually done. Other causes of pleuritic chest pain, such as pulmonary emboli and pneumonia, need to be considered and sometimes ruled out with testing. Treatment is symptomatic, with oral NSAIDs or a short course of oral opioids if needed.

Soruce; Merck Manuals

Add the Pleuritis News Channel to your RSS reader;

PubMed Articles [2568 Associated PubMed Articles listed on BioPortfolio]

Dextrans produced by lactic acid bacteria exhibit antiviral and immunomodulatory activity against salmonid viruses.

Viral infections in the aquaculture of salmonids can lead to high mortality and substantial economic losses. Thus, there is industrial interest in new molecules active against these viruses. Here we d...

Global stability of a multiple delayed viral infection model with general incidence rate and an application to HIV infection.

In this paper, the dynamical behavior of a viral infection model with general incidence rate and two time delays is studied. By using the Lyapunov functional and LaSalle invariance principle, the glob...

A mathematical model of HTLV-I infection with two time delays.

In this paper, we include two time delays in a mathematical model for the CD8+ cytotoxic T lymphocytes (CTLs) response to the Human T-cell leukaemia virus type I (HTLV-I) infection, where one is the i...

Association of Individual and Systemic Barriers to Optimal Medical Care in People Living With HIV/AIDS in Miami-Dade County.

Barriers to retention in HIV care are detrimental to patients' progress along the HIV continuum of care. Previous literature has focused on individual, client-level barriers, and interventions to addr...

Individual and Community Factors Associated With Geographic Clusters of Poor HIV Care Retention and Poor Viral Suppression.

Previous analyses identified specific geographic areas in Philadelphia (hotspots) associated with negative outcomes along the HIV care continuum. We examined individual and community factors associate...

Barriers and Facilitators to Engagement of Vulnerable Populations in HIV Primary Care in New York City.

Engagement in HIV care helps to maximize viral suppression, which in turn, reduces morbidity and mortality and prevents further HIV transmission. With more HIV cases than any other US city, New York C...

Low-level Circulation of Enterovirus D68-Associated Acute Respiratory Infections, Germany, 2014.

We used physician sentinel surveillance to identify 25 (7.7%) mild to severe infections with enterovirus D68 (EV-D68) in children and adults among 325 outpatients with acute respiratory infections in ...

Probable Toxic Cause for Suspected Lychee-Linked Viral Encephalitis.

Recovery of Recombinant Crimean Congo Hemorrhagic Fever Virus Reveals a Function for Non-structural Glycoproteins Cleavage by Furin.

Crimean Congo hemorrhagic fever virus (CCHFV) is a negative-strand RNA virus of the family Bunyaviridae (genus: Nairovirus). In humans, CCHFV causes fever, hemorrhage, severe thrombocytopenia, and hig...

Estimating the In Vivo Killing Efficacy of Cytotoxic T Lymphocytes across Different Peptide-MHC Complex Densities.

Cytotoxic T lymphocytes (CTLs) are important agents in the control of intracellular pathogens, which specifically recognize and kill infected cells. Recently developed experimental methods allow the e...

News Articles [727 Associated News Articles listed on BioPortfolio]

First Report of a New Crop Virus in North America

The switchgrass exhibited mosaic symptoms-splotchy, discolored leaves-characteristic of a viral infection, yet tested negative for known infections. Deep sequencing, a new technology, revealed the pla...

Resource Utilization for Patients Hospitalized for HCV

This new study describes the reasons behind the rise of HCV-related inpatient mortality and resource utilization in the last number of years. Journal of Viral Hepatitis

Sirion Biotech GmbH

SIRION Biotech is specialized service provider for custom viral vectors and knockdown technologies in preclinical target research and therapy development. These technologies enable versatile genetic e...

Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection

Viralytics lifted by FDA panel verdict on T-Vec

The positive verdict of the US FDA's Oncologic Drugs Advisory Committee (ODAC) on Amgen's T-Vec (talimogene laherparepvec) is proving a boost to other companies developing oncolytic immunotherapies, i...

Narconon Arrowhead Issues Guide to Hepatitis Prevention

Canadian, Oklahoma (PRWEB) May 01, 2015 Hepatitis Awareness Month The Centers for Disease Control (CDC) and its public health partners join together in raising public awareness of viral hepatiti...

Putting It Together

Exploring viral replication pathways has led Carol Carter from the study of measles and reoviruses to the assembly and budding of newly minted HIV.

Hide and Seek

Oxford researcher John Frater explains the strategy of targeting viral resevoirs to beat the virus.

Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola

SAN DIEGO, April 30, 2015 /PRNewswire/ -- Tamir Biotechnology, a leading developer of RNA modulating drugs, announced today an update on its Ebola antiviral therapy program. Clinical ProgressOne...

Transfection Tips and Tricks

1.Introduction Transfection is used to modify cells for a wide range of applications, from basic research looking to understand gene function, to establishing disease models, developing new therapeut...

Events [1 Associated Events listed on BioPortfolio]

Viral Safety and Raw Materials Congress: 24-25 June 2015, Vienna, Austria.

Viral Safety and Raw Materials Congress: 24-25 June 2015, Vienna, Austria.

Companies [59 Associated Companies listed on BioPortfolio]

4D Molecular Therapeutics

4DMT is a global leader in gene therapy product research & development. 4DMT and our partners are using scientific innovation to unlock the full potential of gene therapy for pati...

Global Virus Network

The Global Virus Network (GVN) is an independent organization comprised of leading medical virologists from Argentina, Australia, Canada, China, Germany, India, Ireland, Israel, I...

Global Virus Network (GVN)

The Global Virus Network (GVN) is an independent, not for profit organization, comprised of leading medical virologists from Argentina, Australia, Belgium, Canada, China, France, ...

Advanced Biological Laboratories

Advanced Biological Laboratories (ABL), S.A., is a Medical Data Technology company founded in 2000 as a spin-off from CRP-Santé Luxembourg. ABL took control of TherapyEdge, Inc...

Ansun BioPharma

Ansun BioPharma is a clinical stage biopharmaceutical company focused on the development of unique host-directed anti-viral therapies for respiratory viruses. Ansun BioPharma has ...

Meridian Bioscience Inc.

Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and re...

PaxVax Inc.

PaxVax is a privately held specialty vaccine company founded in 2007. PaxVax is focused on traveler vaccines with an emerging pipeline in biodefense coupled with a social mission ...

Adenovir Pharma AB

Adenovir Pharma AB is a development company developing new solutions for treatment of infectious diseases affecting the eyes. Adenovir Pharma was founded by researchers at the department of Virolo...

SillaJen, Inc.

SillaJen, Inc., headquartered in Busan, South Korea with offices in San Francisco, California is a contract R&D company specializing in the translational and clinical development ...

PaxVax Inc

PaxVax is a privately held company established in 2007 to develop and commercialize innovative vaccines against infectious diseases. PaxVax has a clinical-stage product portfolio,...

Clinical Trials [681 Associated Clinical Trials listed on BioPortfolio]

Study of Efficacy and Safety of Grazoprevir (MK-5172)/Elbasvir (MK-8742) Combination Regimen for Treatment-Naïve Participants With Chronic Hepatitis C Virus Genotypes 1, 4, and 6 (MK-5172-060)

This is an efficacy and safety study of grazoprevir (MK-5172) in combination with elbasvir (MK-8742) in treatment-naive participants with chronic hepatitis C virus (HCV) genotype (GT) 1, 4...

Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy

This is a phase 1, single-site study is to evaluate the safety and immunologic and virologic efficacy of ex vivo expanded HIV-1 multi-antigen specific T-cell (HXTC) therapy in HIV-infected...

Fall Epidemic Viral Pediatric Study

Study ADA113872 is an exploratory 16-week multi-centre, randomized, double-blind, parallel group study in pediatric subjects, 4 to 11 years of age, with a history of seasonal asthma exacer...

Durability of Virologic Response and/or Viral Resistance Patterns in Participants With Chronic Hepatitis C Who Have Been Previously Treated With Grazoprevir (MK-5172) (MK-5172-017)

This three-year study (participants with chronic kidney disease [CKD] or cirrhosis will be followed for five years) multicenter study is being done to follow participants who received at l...

Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma

This randomized phase III trial studies how well initial treatment with ipilimumab and nivolumab followed by dabrafenib and trametinib works and compares it to initial treatment with dabra...

Timely Initiation of HIV Antiretroviral Therapy Among Those Who Delay/Decline

This study addresses racial/ethnic disparities in HIV/AIDS treatment. Many persons living with HIV/AIDS (PLHA) in the U.S. (10-19% of PLHA), predominantly African-Americans and Latinos, de...

Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC

The purpose of this study is to assess the efficacy of selumetinib in combination with docetaxel (75mg/m2) vs placebo in combination with docetaxel (75mg/m2) in patients with locally advan...

FST-100 in the Treatment of Acute Viral Conjunctivitis

This randomized, double masked, multi-center study is being conducted to support the safety and efficacy of FST-100 for the treatment of acute viral conjunctivitis. The study intends to sh...

Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma

The purpose of this study is partly to continue the good experience the investigators have with chemotherapy and partly to optimize treatment of inoperable cholangiocarcinoma by adding a b...

Interferon Responses in Eczema Herpeticum (ADEH)

Atopic dermatitis (AD) is a chronic skin disorder characterized by recurrent viral skin infections. A small subset of patients with AD suffer from disseminated viral infections, e.g., ecz...

Medical and Biotech [MESH] Definitions

Proteins associated with the inner surface of the lipid bilayer of the viral envelope. These proteins have been implicated in control of viral transcription and may possibly serve as the "glue" that binds the nucleocapsid to the appropriate membrane site during viral budding from the host cell.

Immunoglobulins produced as a response to VIRAL ANTIGENS; includes all classes of immunoglobulins elicited by all viral components.

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.

A species of gram-negative, facultatively anaerobic coccobacillus-shaped bacteria that has been isolated from pneumonic lesions and blood. It produces pneumonia with accompanying fibrinous pleuritis in swine.

The assembly of VIRAL STRUCTURAL PROTEINS and nucleic acid (VIRAL DNA or VIRAL RNA) to form a VIRUS PARTICLE.

Search BioPortfolio:
Loading
Advertisement

Relevant Topics

Infectious-diseases
Latest News Clinical Trials Research Drugs Reports Corporate
Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, parasites or fungi; the diseases can be spread, directly or indirectly, from one person to another. Zoonotic diseases are infectious diseases of animals that can caus...

Rheumatology
Latest News Clinical Trials Research Drugs Reports Corporate
Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Dictionary). It is an active area of medical research, because of the d...

Anesthesiology
Latest News Clinical Trials Research Drugs Reports Corporate
An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...

Advertisement
review and buy Viral Pleuritis market research data and corporate reports here

Channels Quicklinks